Scientists check cancer Drug's heartbeat risk
NCT ID NCT05630274
Summary
This study tested whether a single dose of the cancer drug selpercatinib (LOXO-292) affects the electrical rhythm of the heart in healthy people. It involved 32 healthy adult volunteers who received the drug, a placebo, and a control medication in a specific order. The main goal was to measure any changes in the heart's QT interval, a key indicator of heart rhythm safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.